Rita Nunes Rato
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Rita Nunes Rato has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Ana Grangeia
Department of Genetics, São João University Hospital, Porto, Portugal
1 shared publication Ana Paula Moreira
Serviço de Medicina Nuclear, Hospitais da Universidade de Coimbra, Unidade Local de Saúde de Coimbra Coimbra Portugal
1 shared publicationAndreia Costa
Neurology Department, Unidade Local de Saúde de São João, Porto, Portugal; Department of Neurosciences and Mental Health, Faculty of Medicine, University of Porto, Porto, Portugal
1 shared publication- Andreia Costa
Unidade Local de Saúde de São João, Departamento de Neurologia, Porto, Portugal
1 shared publication - André Fernandes
Department of Neurology, São João University Hospital, Porto, Portugal; Department of Clinical Neurosciences and Mental Health, Faculty of Medicine, University of Porto, Porto, Portugal
1 shared publication - Bárbara Martins
Serviço de Neurologia Hospital Universitário São João Porto Portugal
1 shared publication
Latest Publications
- Open Access
- 10 February 2026
- Published by Sociedade Portuguesa de Neurologia in Sinapse
- Vol. 26 (1) , 22-30
Acute non-neoplastic myelopathies in pediatric age: a decade of experience from a pediatric center
Introduction: Pediatric myelopathies encompass a broad range of non-traumatic and non-neoplastic etiologies, including inflammatory, vascular, and infectious causes. Despite their low prevalence, the differential diagnosis and management of these conditions remain challenging due to the diversity of clinical manifestations and progression patterns. Methods: A retrospective observational study was conducted, including children up to 18 years of age diagnosed with acute non-neoplastic myelopathy at our pediatric center between 2010 and 2021. Clinical data, complementary examinations, treatments, and functional outcomes were analyzed from hospital records, with a comparison across different etiologies. Results: Thirty-six cases were included (50% male), with a mean age at diagnosis of 10.8 years (SD±5.3 years). The identified etiologies were: demyelinating and inflammatory (16 cases), vascular (13), infectious (3), and idiopathic (4). Muscle weakness was the most frequent initial symptom (68.9%), followed by sensory complaints (48.3%). Pain as a presenting symptom was reported in 20% of cases and was associated with idiopathic etiology (p=0.05)(p=0.05). Hyperacute onset was characteristic of vascular myelopathies (p<0.001)(p<0.001) whereas 75% of demyelinating and inflammatory myelopathies presented with subacute onset. Magnetic resonance imaging (MRI) findings revealed that brain lesions were more associated with demyelinating and inflammatory etiologies (p=0.003)(p=0.003), while anterior spinal cord lesions in axial sections were linked to vascular etiologies (p=0.018)(p=0.018). A worse functional outcome was observed in cases with hyperacute symptom onset (p=0.024)(p=0.024). Conclusion: Pediatric myelopathies exhibit distinct clinical and radiological features depending on the etiology. Symptom onset and imaging findings play a critical role in both etiological identification and functional prognosis. The sample from this study displays characteristics consistent with the existing literature. Understanding the particularities of these conditions, particularly in the pediatric population, is essential for defining an effective clinical approach with the potential to positively impact the quality of life of patients and their families.
- 10 February 2026
- Published by Sociedade Portuguesa de Neurologia in Sinapse
- Vol. 26 (1) , 22-30
Open AccessAcute non-neoplastic myelopathies in pediatric age: a decade of experience from a pediatric center
Introduction: Pediatric myelopathies encompass a broad range of non-traumatic and non-neoplastic etiologies, including inflammatory, vascular, and infectious causes. Despite their low prevalence, the differential diagnosis and management of these conditions remain challenging due to the diversity of clinical manifestations and progression patterns. Methods: A retrospective observational study was conducted, including children up to 18 years of age diagnosed with acute non-neoplastic myelopathy at our pediatric center between 2010 and 2021. Clinical data, complementary examinations, treatments, and functional outcomes were analyzed from hospital records, with a comparison across different etiologies. Results: Thirty-six cases were included (50% male), with a mean age at diagnosis of 10.8 years (SD±5.3 years). The identified etiologies were: demyelinating and inflammatory (16 cases), vascular (13), infectious (3), and idiopathic (4). Muscle weakness was the most frequent initial symptom (68.9%), followed by sensory complaints (48.3%). Pain as a presenting symptom was reported in 20% of cases and was associated with idiopathic etiology (p=0.05)(p=0.05). Hyperacute onset was characteristic of vascular myelopathies (p<0.001)(p<0.001) whereas 75% of demyelinating and inflammatory myelopathies presented with subacute onset. Magnetic resonance imaging (MRI) findings revealed that brain lesions were more associated with demyelinating and inflammatory etiologies (p=0.003)(p=0.003), while anterior spinal cord lesions in axial sections were linked to vascular etiologies (p=0.018)(p=0.018). A worse functional outcome was observed in cases with hyperacute symptom onset (p=0.024)(p=0.024). Conclusion: Pediatric myelopathies exhibit distinct clinical and radiological features depending on the etiology. Symptom onset and imaging findings play a critical role in both etiological identification and functional prognosis. The sample from this study displays characteristics consistent with the existing literature. Understanding the particularities of these conditions, particularly in the pediatric population, is essential for defining an effective clinical approach with the potential to positively impact the quality of life of patients and their families.
- 4 December 2025
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 152, 108140
Atypical parkinsonism with dystonia and bulbar dysfunction with a ATP1A3 gene disease-causing variant
- 4 December 2025
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 152, 108140
Atypical parkinsonism with dystonia and bulbar dysfunction with a ATP1A3 gene disease-causing variant
- Open Access
- 29 October 2025
- Published by Sociedade Portuguesa de Neurologia in Sinapse
- Vol. 25 (4) , 186-190
Non-Alcohol-Related Wernicke Encephalopathy
A 39-year-old male with a recent diagnosis of human immunodeficiency virus infection, in the AIDS stage, and Burkitt lymphoma, both identified in the context of a constitutional syndrome with six months of evolution developed an acute condition with psychomotor slowing, disorientation, and gait imbalance, six weeks after initiating antiretroviral therapy and chemotherapy. Neurological examination revealed multidirectional nystagmus, length-dependent sensory disturbance, and severe appendicular and gait ataxia. Brain MRI showed symmetrical hyperintensity in the medial thalami, extending to the posterior midbrain, pons, and medulla. With a clinical suspicion of Wernicke’s encephalopathy, high-dose intravenous thiamine supplementation was initiated, resulting in rapid clinical improvement and imaging regression of the lesions. This case highlights an atypical and potentially reversible presentation of Wernicke’s encephalopathy, underscoring the importance of clinical suspicion in patients with severe cachexia, hematologic malignancies, or other conditions that impair thiamine absorption.
- 29 October 2025
- Published by Sociedade Portuguesa de Neurologia in Sinapse
- Vol. 25 (4) , 186-190
Open AccessNon-Alcohol-Related Wernicke Encephalopathy
A 39-year-old male with a recent diagnosis of human immunodeficiency virus infection, in the AIDS stage, and Burkitt lymphoma, both identified in the context of a constitutional syndrome with six months of evolution developed an acute condition with psychomotor slowing, disorientation, and gait imbalance, six weeks after initiating antiretroviral therapy and chemotherapy. Neurological examination revealed multidirectional nystagmus, length-dependent sensory disturbance, and severe appendicular and gait ataxia. Brain MRI showed symmetrical hyperintensity in the medial thalami, extending to the posterior midbrain, pons, and medulla. With a clinical suspicion of Wernicke’s encephalopathy, high-dose intravenous thiamine supplementation was initiated, resulting in rapid clinical improvement and imaging regression of the lesions. This case highlights an atypical and potentially reversible presentation of Wernicke’s encephalopathy, underscoring the importance of clinical suspicion in patients with severe cachexia, hematologic malignancies, or other conditions that impair thiamine absorption.
- 19 May 2025
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 12 (7) , 1009-1010
Parkinsonism Associated with Posterior Cortical Atrophy: Atypical Alzheimer's Disease
- 19 May 2025
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 12 (7) , 1009-1010
Parkinsonism Associated with Posterior Cortical Atrophy: Atypical Alzheimer's Disease